Analysis of Apps With a Medication List Functionality for Older Adults With Heart Failure Using the Mobile App Rating Scale and the IMS Institute for Healthcare Informatics Functionality Score: Evaluation Study.
Mobile App Rating Scale
heart failure
mHealth
medication app
mobile app
Journal
JMIR mHealth and uHealth
ISSN: 2291-5222
Titre abrégé: JMIR Mhealth Uhealth
Pays: Canada
ID NLM: 101624439
Informations de publication
Date de publication:
02 11 2021
02 11 2021
Historique:
received:
24
05
2021
accepted:
14
07
2021
revised:
08
07
2021
entrez:
2
11
2021
pubmed:
3
11
2021
medline:
6
11
2021
Statut:
epublish
Résumé
Managing the care of older adults with heart failure (HF) largely centers on medication management. Because of frequent medication or dosing changes, an app that supports these older adults in keeping an up-to-date list of medications could be advantageous. During the COVID-19 pandemic, HF outpatient consultations are taking place virtually or by telephone. An app with the capability to share a patient's medication list with health care professionals before consultation could support clinical efficiency, for example, by reducing consultation time. However, the influence of apps on maintaining an up-to-date medication history for older adults with HF in Ireland remains largely unexplored. The aims of this review are twofold: to review apps with a medication list functionality and to assess the quality of the apps included in the review using the Mobile App Rating Scale (MARS) and the IMS Institute for Healthcare Informatics functionality scale. A systematic search of apps was conducted in June 2019 using the Google Play Store and iTunes App Store. The MARS was used independently by 4 researchers to assess the quality of the apps using an Android phone and an iPad. Apps were also evaluated using the IMS Institute for Healthcare Informatics functionality score. Google Play and iTunes App store searches identified 483 potential apps (292 from Google Play and 191 from iTunes App stores). A total of 6 apps (3 across both stores) met the inclusion criteria. Of the 6 apps, 4 achieved an acceptable MARS score (3/5). The Medisafe app had the highest overall MARS score (4/5), and the Medication List & Medical Records app had the lowest overall score (2.5/5). On average, the apps had 8 functions based on the IMS functionality criteria (range 5-11). A total of 2 apps achieved the maximum score for number of features (11 features) according to the IMS Institute for Healthcare Informatics functionality score, and 2 scored the lowest (5 features). Peer-reviewed publications were identified for 3 of the apps. The quality of current apps with medication list functionality varies according to their technical aspects. Most of the apps reviewed have an acceptable MARS objective quality (ie, the overall quality of an app). However, subjective quality (ie, satisfaction with the apps) was poor. Only 3 apps are based on scientific evidence and have been tested previously. A total of 2 apps featured all the IMS Institute for Healthcare Informatics functionalities, and half did not provide clear instructions on how to enter medication data, did not display vital parameter data in an easy-to-understand format, and did not guide users on how or when to take their medication.
Sections du résumé
BACKGROUND
Managing the care of older adults with heart failure (HF) largely centers on medication management. Because of frequent medication or dosing changes, an app that supports these older adults in keeping an up-to-date list of medications could be advantageous. During the COVID-19 pandemic, HF outpatient consultations are taking place virtually or by telephone. An app with the capability to share a patient's medication list with health care professionals before consultation could support clinical efficiency, for example, by reducing consultation time. However, the influence of apps on maintaining an up-to-date medication history for older adults with HF in Ireland remains largely unexplored.
OBJECTIVE
The aims of this review are twofold: to review apps with a medication list functionality and to assess the quality of the apps included in the review using the Mobile App Rating Scale (MARS) and the IMS Institute for Healthcare Informatics functionality scale.
METHODS
A systematic search of apps was conducted in June 2019 using the Google Play Store and iTunes App Store. The MARS was used independently by 4 researchers to assess the quality of the apps using an Android phone and an iPad. Apps were also evaluated using the IMS Institute for Healthcare Informatics functionality score.
RESULTS
Google Play and iTunes App store searches identified 483 potential apps (292 from Google Play and 191 from iTunes App stores). A total of 6 apps (3 across both stores) met the inclusion criteria. Of the 6 apps, 4 achieved an acceptable MARS score (3/5). The Medisafe app had the highest overall MARS score (4/5), and the Medication List & Medical Records app had the lowest overall score (2.5/5). On average, the apps had 8 functions based on the IMS functionality criteria (range 5-11). A total of 2 apps achieved the maximum score for number of features (11 features) according to the IMS Institute for Healthcare Informatics functionality score, and 2 scored the lowest (5 features). Peer-reviewed publications were identified for 3 of the apps.
CONCLUSIONS
The quality of current apps with medication list functionality varies according to their technical aspects. Most of the apps reviewed have an acceptable MARS objective quality (ie, the overall quality of an app). However, subjective quality (ie, satisfaction with the apps) was poor. Only 3 apps are based on scientific evidence and have been tested previously. A total of 2 apps featured all the IMS Institute for Healthcare Informatics functionalities, and half did not provide clear instructions on how to enter medication data, did not display vital parameter data in an easy-to-understand format, and did not guide users on how or when to take their medication.
Identifiants
pubmed: 34726613
pii: v9i11e30674
doi: 10.2196/30674
pmc: PMC8596242
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e30674Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Informations de copyright
©Yohanca Maria Diaz-Skeete, David McQuaid, Adewale Samuel Akinosun, Idongesit Ekerete, Natacha Carragher, Lucia Carragher. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 02.11.2021.
Références
Oncol Nurs Forum. 2018 Jan 1;45(1):69-76
pubmed: 29251285
JAMA Intern Med. 2018 Jun 1;178(6):802-809
pubmed: 29710289
JMIR Mhealth Uhealth. 2019 Sep 12;7(9):e14914
pubmed: 31516127
Int J Med Inform. 2017 May;101:68-74
pubmed: 28347449
JMIR Cardio. 2017 Aug 11;1(2):e3
pubmed: 31758759
Aust N Z J Public Health. 2017 Dec;41(6):625-630
pubmed: 28749591
Curr Treat Options Cardiovasc Med. 2010 Jan;12(1):1-9
pubmed: 20842477
Scand Cardiovasc J. 2015 Aug;49(4):193-9
pubmed: 25968968
Lancet Digit Health. 2019 Jun;1(2):e55-e57
pubmed: 33323230
JMIR Ment Health. 2020 Mar 26;7(3):e18848
pubmed: 32213476
JAMA. 2017 May 23;317(20):2057-2058
pubmed: 28426844
BMC Med. 2018 Dec 3;16(1):225
pubmed: 30501638
JMIR Mhealth Uhealth. 2019 May 28;7(5):e13645
pubmed: 31140434
Am J Prev Med. 2013 Nov;45(5):583-9
pubmed: 24139771
Am Heart J. 2016 Aug;178:85-94
pubmed: 27502855
Nat Rev Cardiol. 2011 Jan;8(1):30-41
pubmed: 21060326
Can Pharm J (Ott). 2016 Dec 06;150(1):60-66
pubmed: 28286594
Stud Health Technol Inform. 2017;235:68-72
pubmed: 28423757
JMIR Hum Factors. 2019 May 02;6(2):e13009
pubmed: 31045504
Lancet Public Health. 2020 Jan;5(1):e62-e70
pubmed: 31910981
West J Emerg Med. 2020 Apr 14;21(3):514-525
pubmed: 32302279
Eur J Heart Fail. 2009 Jun;11(6):617-21
pubmed: 19414477
JMIR Cardio. 2018 May 02;2(1):e10057
pubmed: 31758762
BMJ Open. 2020 Nov 6;10(11):e042555
pubmed: 33158839
J Telemed Telecare. 2014 Sep;20(6):293-9
pubmed: 24958355
Ir J Psychol Med. 2021 Jun;38(2):132-139
pubmed: 32438945
JMIR Mhealth Uhealth. 2020 Jul 2;8(7):e18868
pubmed: 32459640
Lancet. 2020 Apr 11;395(10231):1180-1181
pubmed: 32278374
Aust Fam Physician. 2012 Dec;41(12):924-8
pubmed: 23210113
JMIR Mhealth Uhealth. 2014 Mar 14;2(1):e11
pubmed: 25099993
J Card Fail. 2017 Mar;23(3):252-256
pubmed: 27742454
J Med Internet Res. 2015 Aug 17;17(8):e198
pubmed: 26283290
Ir J Psychol Med. 2020 Jul 02;:1-5
pubmed: 32611473
JMIR Form Res. 2017 Nov 10;1(1):e5
pubmed: 30684397
Card Fail Rev. 2020 May 25;6:e13
pubmed: 32537246
Med Sci (Basel). 2019 Jun 04;7(6):
pubmed: 31167489
Harv Rev Psychiatry. 2018 Jul/Aug;26(4):175-184
pubmed: 29975336
Eur J Heart Fail. 2019 Mar;21(3):286-296
pubmed: 30537163
Medicine (Baltimore). 2016 Sep;95(36):e4446
pubmed: 27603339
Pharmacy (Basel). 2018 Feb 28;6(1):
pubmed: 29495567
JMIR Mhealth Uhealth. 2016 Jun 14;4(2):e74
pubmed: 27302310
Can J Cardiol. 2020 Jul;36(7):1148-1151
pubmed: 32405146
PLoS Med. 2010 Jul 27;7(7):e1000316
pubmed: 20668659
Assist Technol. 2020;32(2):109-116
pubmed: 29944463
Lancet Public Health. 2020 May;5(5):e256
pubmed: 32199471
JMIR Mhealth Uhealth. 2020 May 27;8(5):e17300
pubmed: 32459187
Can J Cardiol. 2016 Sep;32(9):1140-7
pubmed: 27476982
BMJ. 2020 Mar 12;368:m998
pubmed: 32165352
JMIR Mhealth Uhealth. 2015 Mar 11;3(1):e27
pubmed: 25760773
J Med Syst. 2018 May 29;42(7):119
pubmed: 29845455
Int J Med Inform. 2018 Jun;114:66-75
pubmed: 29673606